Angionesis inhibitors: New agents in cancer therapy

Keyphrases

• In Cancer 100%
• Angiogenesis 100%
• Cancer Therapy 100%
• New Agents 100%
• Angiogenesis Inhibitors 100%
• Clinical Trials 66%
• Tumor 66%
• Biological Effects 66%
• Toxic Effects 66%
• Cell Membrane 33%
• Therapeutic Target 33%
• Endothelial Cells 33%
• Integrin 33%
• Cytotoxic Chemotherapy 33%
• Clinical Investigator 33%
• Cell-mediated 33%
• Antitumor Effect 33%
• Adhesion Molecules 33%
• Metalloproteinases 33%
• Vascular Endothelial Growth Factor 33%
• Blood Supply 33%
• Extracellular Matrix Protein 1 (ECM1) 33%
• Extracellular Matrix Degradation 33%
• Metastatic Spread 33%
• Endostatin 33%
• Molecular Processes 33%
• Cytokine Production 33%
• Aggressive Tumor 33%
• Tumor Behavior 33%
• Agent Types 33%
• Membrane Adhesion 33%
• Tumor Blood Supply 33%
• Evidence-making 33%
• Novel Anticancer Agents 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Angiogenesis Inhibitor 100%
• Clinical Trial 66%
• Cytotoxic Chemotherapy 33%
• Anticarcinogen 33%
• Integrin 33%
• Vasculotropin 33%
• Cytokine 33%
• Tumor Vascularization 33%
• Metalloproteinase 33%
• Scleroprotein 33%
• Cell Adhesion Proteins 33%
• Endostatin 33%